| Literature DB >> 34609500 |
Anabela Bensimon-Brito1,2, Giulia L M Boezio1,2, João Cardeira-da-Silva1,2, Astrid Wietelmann3, Srinath Ramkumar1,2,4, Pia R Lundegaard5,6, Christian S M Helker1, Radhan Ramadass1, Janett Piesker7, Arno Nauerth8, Clemens Mueller9, Didier Y R Stainier1,2.
Abstract
AIMS: Mammalian models have been instrumental in investigating adult heart function and human disease. However, electrophysiological differences with human hearts and high costs motivate the need for non-mammalian models. The zebrafish is a well-established genetic model to study cardiovascular development and function; however, analysis of cardiovascular phenotypes in adult specimens is particularly challenging as they are opaque. METHODS ANDEntities:
Keywords: Aorta; Cardiovascular; Electrophysiology; MRI; Multi-modal imaging; Pre-clinical; TGFß signalling
Mesh:
Year: 2022 PMID: 34609500 PMCID: PMC9491864 DOI: 10.1093/cvr/cvab310
Source DB: PubMed Journal: Cardiovasc Res ISSN: 0008-6363 Impact factor: 13.081
Figure 1alk5a –/– adult zebrafish display variable cardiac phenotypes without gross morphological defects. (A) Schematic of Alk5a WT and mutant proteins depicting each domain and the site of the mutation (star). (B, C) Brightfield images of 9 mpf WT (B) and alk5a (C) zebrafish. (D, E) Brightfield images of alk5a hearts (E) which occasionally exhibit a dilated outflow tract (OFT) lumen compared to WT (D). (F–I) Cryosections of WT (F, H) and alk5a (G, I) hearts immunostained for Tg(kdrl: eGFP) expression (endothelial cells) and Elastin2 (F, G), and stained for haematoxylin-eosin (H, I) showing the expanded OFT lumen (Lu, dashed line) in alk5a zebrafish. (J–L) Quantification of age (J), standard length (K), and body volume (L) of WT (n = 10) and alk5a (n = 12) zebrafish used in the subsequent analyses. Plots show the values for each individual and the mean ± SD; P-values were determined by unpaired t-test (J, L) or Mann–Whitney test (K). The colour of each dot refers to the same zebrafish across all graphs. The dot adjacent to the number symbol (#) identifies the individual zebrafish mentioned in the text. Scale bars: 2 mm (B, C), 200 µm (D, E, H, I), 400 µm (F, G). A, atrium; EC, extracellular; GS, glycine–serine rich; SP, signal peptide; STK, serine–threonine kinase; TM, transmembrane; V, ventricle.
Figure 7Sequential in vivo measurements allow the observation of phenotype progression. (A) Experimental setup for the sequential monthly measurements (t1, t2, t3) performed with echocardiography in WT and alk5a in control conditions (n = 7 WT, n = 6 alk5a) and upon treatment with isoprenaline (+ISO; n = 7 WT, n = 7 alk5a). (B–F) Graphs showing changes in OFT (B) and AVC (C) regurgitation in WT and alk5a adult zebrafish untreated or treated with isoprenaline. (G–I) Zebrafish # 2, which displays the most pronounced increase in the regurgitation fraction in the OFT from t1 to t3 (G), presented an enlarged OFT lumen in some histological sections (H) but not in others (I). Scale bars: 1 mm (D–G), 400 µm (H, I).
Inter-observer measurements for ventricular outer wall and luminal expansion
| Ventricular outer wall (%) | Ventricular lumen (%) | |||||
|---|---|---|---|---|---|---|
| Fish | Sample mean | Observer 1 | Observer 2 | Sample mean | Observer 1 | Observer 2 |
| WT 1 | 12 | 8 | 24 | 29 | ||
| WT 2 | 20 | 24 | 56 | 62 | ||
| WT 3 | 1 | 4 | 16 | 26 | ||
| WT 4 | 6 | 1 | 10 | 6 | ||
| WT 5 | 9.8 | 3 | 2 | 27.4 | 10 | 13 |
| WT 6 | 5 | 11 | 22 | 37 | ||
| WT 7 | 5 | 1 | 17 | 16 | ||
| WT 8 | 12 | 12 | 36 | 29 | ||
| WT 9 | 25 | 12 | 31 | 51 | ||
| WT 10 | 20 | 12 | 33 | 23 | ||
| Mean | 10.9 | 8.7 | 25.5 | 29.2 | ||
| MUT 1 | 19 | 19 | 64 | 62 | ||
| MUT 2 | 4 | 1 | 40 | 35 | ||
| MUT 3 | 1 | 1 | 53 | 41 | ||
| MUT 4 | 11 | 11 | 17 | 25 | ||
| MUT 5 | 6 | 5 | 35 | 28 | ||
| MUT 6 | 9.1 | 12 | 9 | 31.3 | 14 | 21 |
| MUT 7 | 7 | 2 | 18 | 23 | ||
| MUT 8 | 3 | 5 | 34 | 25 | ||
| MUT 9 | 4 | 8 | 16 | 25 | ||
| MUT 10 | 40 | 1 | 51 | 21 | ||
| MUT 11 | 20 | 15 | 19 | 29 | ||
| MUT 12 | 10 | 4 | 31 | 23 | ||
| Mean | 11.4 | 6.8 | 32.7 | 29.8 | ||
Inter-observer measurements for outflow tract outer wall and luminal expansion
| Outflow outer wall (%) | Outflow lumen (%) | |||||
|---|---|---|---|---|---|---|
| Fish | Sample mean | Observer 1 | Observer 2 | Sample mean | Observer 1 | Observer 2 |
| WT 1 | 5 | 3 | 14 | 7 | ||
| WT 2 | 4 | 8 | 12 | 9 | ||
| WT 3 | 3 | 8 | 11 | 6 | ||
| WT 4 | 7 | 6 | 11 | 8 | ||
| WT 5 | 6.4 | 11 | 4 | 11.5 | 12 | 15 |
| WT 6 | 14 | 3 | 13 | 13 | ||
| WT 7 | 5 | 3 | 21 | 15 | ||
| WT 8 | 12 | 8 | 7 | 7 | ||
| WT 9 | 10 | 5 | 14 | 8 | ||
| WT 10 | 3 | 5 | 12 | 14 | ||
| Mean | 7.4 | 5.3 | 12.7 | 10.2 | ||
| MUT 1 | 2 | 4 | 34 | 27 | ||
| MUT 2 | 11 | 9 | 36 | 27 | ||
| MUT 3 | 7 | 6 | 41 | 41 | ||
| MUT 4 | 14 | 10 | 9 | 15 | ||
| MUT 5 | 5 | 12 | 33 | 35 | ||
| MUT 6 | 6.8 | 8 | 6 | 34.1 | 30 | 45 |
| MUT 7 | 2 | 6 | 38 | 40 | ||
| MUT 8 | 7 | 5 | 34 | 33 | ||
| MUT 9 | 5 | 3 | 31 | 38 | ||
| MUT 10 | 9 | 2 | 46 | 30 | ||
| MUT 11 | 7 | 9 | 44 | 36 | ||
| MUT 12 | 6 | 9 | 44 | 31 | ||
| Mean | 6.9 | 6.8 | 35.0 | 33.2 | ||
Description and abbreviation terms for each parameter
| Parameter | Abbreviation | Description |
|---|---|---|
| Standard length | Std. length | Length from the anterior tip of the snout to the anterior part of the caudal fin |
| Body volume | Body vol. | Three-dimensional space occupied by the fish body |
| Outflow tract velocity time integral | OFT VTI | Area within the Doppler curve (integral). It indicates how far blood travels during the flow period and it is a measure of cardiac systolic function and cardiac output. |
| Outflow tract mean velocity | OFT mean velocity | Average of the instantaneous velocity from the outflow curve for each heartbeat, measured from all cardiac cycles across 10 s |
| Outflow tract mean gradient | OFT mean gradient | Average of the instantaneous pressure gradients over the entire outflow Doppler curve, measured from all cardiac cycles across 10 s |
| Outflow tract velocity peak velocity | OFT peak velocity | Maximum velocity of the blood passing from the ventricle to the outflow tract; Vmax |
| Outflow tract velocity peak gradient | OFT peak gradient | Pressure gradient calculated from the peak velocity with the Bernoulli equation: 4(Vmax)2 |
| Ejection time | Ejection time | Period of blood flow from ventricle to the outflow tract |
| Heart rate | Heart rate | The speed at which the heart beats measured in beats per minute |
| Area aortic flow | Area aortic flow | Amount of blood (in a 2D plane) detected in the aorta |
| Area inflow | Area inflow | Amount of blood (in a 2D plane) going from the atrium to the ventricle |
| Area outflow | Area outflow | Amount of blood (in a 2D plane) going from the ventricle to the outflow tract |
| Regurgitation fraction in the atrioventricular canal | Regurg. fraction AVC | Relative amount of blood (in a 2D plane) that returns to the atrium during ventricular contraction (systole); inflow area/retrograde flow area |
| Regurgitation fraction in the outflow tract | Regurg. fraction OFT | Relative amount of blood (in a 2D plane) that returns to the ventricle after ventricular contraction (systole); outflow area/retrograde flow area |
| Percentage ventricular luminal expansion | % Vent. lum. exp. | Lumen displacement between minimum and maximum ventricular contraction in a cardiac cycle |
| Percentage ventricular outer wall expansion | % Vent. outer wall exp. | Outer wall displacement between minimum and maximum ventricular contraction in a cardiac cycle |
| Percentage outflow tract luminal expansion | % OFT lum. exp. | Lumen displacement between minimum and maximum outflow tract expansion in a cardiac cycle |
| Percentage outflow tract outer wall expansion | % OFT outer wall exp. | Outer wall displacement between minimum and maximum outflow tract expansion in a cardiac cycle |
| Heart volume | Heart vol. | Three-dimensional space occupied by the heart—calculated by the sum of the volumes of each cardiac compartment |
| Ventricular volume | Vent. vol. | Three-dimensional space occupied by the ventricle—including the lumen |
| Percentage ventricular volume | % Vent. vol. | Relative volume of the ventricle in relation to the entire heart |
| Atrial volume | Atrial vol. | Three-dimensional space occupied by the atrium—including the lumen |
| Percentage atrial volume | % Atrial vol. | Relative volume of the atrium in relation to the entire heart |
| Outflow tract volume | OFT vol. | Three-dimensional space occupied by the outflow tract—including the lumen |
| Percentage of outflow tract volume | % OFT vol. | Relative volume of the outflow tract in relation to the entire heart |
| Outflow tract luminal volume | OFT lum. vol. | Three-dimensional space occupied by the outflow tract lumen |
| Percentage outflow tract luminal volume | % OFT lum. vol. | Relative volume of the outflow tract lumen in relation to the entire outflow tract |
| Outflow tract wall volume | OFT wall vol. | Three-dimensional space occupied by the outflow tract wall; |
| Aortic diameter | Aortic diam. | Maximum diameter of the aorta measured in the most proximal linear portion of the aorta |
| Aortic volume | Aortic vol. | Three-dimensional space occupied by the aorta anteriorly to the heart |
Biological features
| Wild type (WT) |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Parameters | Median | Minimum | Maximum | Inter-quartile range (IQR) | Median | Minimum | Maximum | Inter-quartile range (IQR) |
|
| Age (months) | 8.5 | 6.0 | 14.0 | 6.0–13.3 | 12 | 6.0 | 14.0 | 6.0–14.0 | 0.3766 |
| Std. length (mm) | 3.2 | 2.9 | 3.5 | 3.1–3.3 | 3.3 | 2.6 | 3.5 | 3.2–3.3 | 0.6054 |
| Body vol. (mm3) | 0.68 | 0.45 | 0.75 | 0.56–0.74 | 0.65 | 0.40 | 1.10 | 0.56–0.83 | 0.0578 |
Echocardiography parameters
| Wild type (WT) |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Parameters | Median | Minimum | Maximum | Inter-quartile range (IQR) | Median | Minimum | Maximum | Inter-quartile range (IQR) |
|
| OFT VTI (mm) | 12.3 | 6.9 | 28.5 | 11.2–19.4 | 11.8 | 1.8 | 20.3 | 9.2–16.4 | 0.2997 |
| OFT mean velocity (mm/s) | 77.4 | 44.7 | 132.0 | 64.4–94.9 | 75.2 | 17.6 | 123.5 | 59.6–95.3 | 0.5757 |
| OFT mean gradient (mm Hg) | 0.024 | 0.008 | 0.070 | 0.017–0.036 | 0.022 | 0.001 | 0.062 | 0.014–0.037 | 0.5903 |
| OFT peak velocity (mm/s) | 110.4 | 59.7 | 186.1 | 86.6–128.9 | 98.9 | 25.6 | 171.8 | 82.4–129.4 | 0.5278 |
| OFT peak gradient (mm Hg) | 0.050 | 0.014 | 0.139 | 0.030–0.067 | 0.040 | 0.003 | 0.119 | 0.027–0.066 | 0.5229 |
| Ejection time (s) | 0.182 | 0.136 | 0.246 | 0.159–0.200 | 0.157 | 0.103 | 0.237 | 0.137–0.181 | 0.1947 |
| Heart rate (bpm) | 107.8 | 58.4 | 131.5 | 87.4–118.9 | 98.4 | 61.0 | 143.5 | 84.8–112.3 | 0.8138 |
| Area aortic flow (×103 mm2) | 0 | 0 | 0.67 | 0 | 0 | 0 | 3.79 | 0–0.161 | 0.1729 |
| Area inflow (×104 AU) | 0.81 | 0.45 | 1.24 | 0.67–0.97 | 0.52 | 0.04 | 3.69 | 0.38–0.82 | 0.1583 |
| Area outflow (×103 AU) | 6.40 | 3.27 | 11.75 | 5.22–6.89 | 4.12 | 0.56 | 10.09 | 3.47–5.90 | 0.1447 |
| Regurg. fraction AVC (%) | 0 | 0 | 11.2 | 0–1.2 | 2.6 | 0 | 84.0 | 0–27.0 | 0.1732 |
| Regurg. fraction OFT (%) | 0 | 0 | 24.4 | 0 | 6.0 | 0 | 55.1 | 0–16.0 | 0.0847 |
MRI parameters
| Wild type (WT) |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Parameters | Median | Minimum | Maximum | Inter-quartile range (IQR) | Median | Minimum | Maximum | Inter-quartile range (IQR) |
|
| Vent. lum. exp. (%) | 27.3 | 8.0 | 59.0 | 17.6–31.8 | 28.3 | 17.5 | 63.0 | 20.9–36.4 | 0.5277 |
| Vent. outer wall exp. (%) | 9.0 | 2.5 | 22.0 | 3.1–15.0 | 6.5 | 1.0 | 20.5 | 4.4–12.6 | 0.8107 |
| OFT lum. exp. (%) | 10.8 | 7.0 | 18.0 | 9.8–13.0 | 36.0 | 12.0 | 41.0 | 33.0–38.3 | <0.0001 |
| OFT outer wall exp. (%) | 6.3 | 4.0 | 10.0 | 4.4–7.5 | 6.8 | 3.0 | 12.0 | 5.1–8.1 | 0.6395 |
Micro-CT parameters
| Wild type (WT) |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Parameters | Median | Minimum | Maximum | Inter-quartile range (IQR) | Median | Minimum | Maximum | Inter-quartile range (IQR) |
|
| Heart vol. (×109 µm3) | 3.11 | 2.18 | 4.20 | 2.49–3.84 | 2.95 | 1.67 | 7.67 | 2.74–3.62 | 0.9022 |
| Vent. vol. (×108 µm3) | 1.40 | 1.00 | 2.00 | 1.19–1.75 | 1.41 | 6.07 | 1.99 | 9.28–10.53 | 0.3142 |
| Vent. vol. (%) | 46.00 | 34.20 | 61.00 | 43.3–49.5 | 46.00 | 8.10 | 53.50 | 41.7–49.6 | 0.9094 |
| Atrial vol. (×109 µm3) | 1.33 | 9.91 | 2.41 | 1.08–2.01 | 1.38 | 9.68 | 6.96 | 1.12–1.78 | 0.9370 |
| Atrial vol. (%) | 48.30 | 30.20 | 61.40 | 43.4–51.0 | 48.00 | 39.40 | 90.70 | 43.8–54.4 | 0.7354 |
| OFT vol. (×108 µm3) | 1.78 | 1.15 | 2.90 | 1.52–2.27 | 1.82 | 6.02 | 2.13 | 1.06–1.86 | 0.1074 |
| OFT vol. (%) | 6.20 | 4.40 | 8.80 | 4.9–7.1 | 5.40 | 1.30 | 7.20 | 3.9–6.6 | 0.1328 |
| OFT lum. vol. (×107 µm3) | 0.78 | 0.16 | 2.30 | 0.59–1.50 | 2.19 | 0.25 | 4.95 | 1.08–2.90 | 0.1328 |
| OFT lum. vol. (%) | 4.00 | 1.10 | 10.70 | 0.3–0.7 | 11.60 | 4.20 | 51.50 | 7.5–14.9 |
|
| OFT wall vol. (×108 µm3) | 1.72 | 1.13 | 2.69 | 1.46–2.09 | 1.59 | 0.47 | 1.83 | 0.91–1.71 |
|
| Aortic diam. (µm) | 193.00 | 138.00 | 253.00 | 157.8–199.0 | 196.00 | 148.00 | 300.00 | 169.5–258.3 | 0.1724 |
| Aortic vol. (×107 µm3) | 4.06 | 2.17 | 7.73 | 3.31–6.46 | 4.09 | 1.55 | 9.64 | 3.18–6.63 | 0.8638 |
Regurgitation fraction values obtained in the sequential echocardiography measurements (related to Figure 7)
| WT (%) |
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | +ISO | Control | +ISO | ||||||||||
| Zebrafish | t1 | t2 | t3 | t1 | t2 | t3 | t1 | t2 | t3 | t1 | t2 | t3 | |
| Regurgitation fraction OFT | 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.9 | 11.6 |
| 2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.9 | 51.9 | 39.4 | 83.1 | |
| 3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 90.7 | 100.0 | 100.0 | 0.0 | 0.0 | 0.9 | |
| 5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 23.9 | 44.9 | 28.3 | |
| 6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.2 | ||||
| Regurgitation fraction AVC | 1 | 1.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.3 | 0.0 | 0.0 | 0.0 | 0.1 | 21.4 |
| 2 | 1.4 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 | 0.8 | 21.5 | 0.0 | 0.0 | 1.4 | |
| 3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 56.7 | 39.2 | 68.7 | |
| 4 | 15.3 | 0.0 | 0.0 | 12.4 | 0.0 | 12.5 | 100.0 | 100.0 | 100.0 | 0.0 | 39.4 | 40.7 | |
| 5 | 0.0 | 0.0 | 0.0 | 45.2 | 7.2 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 30.7 | 4.1 | 55.4 | 0.0 | 0.0 | 76.3 | |
| 7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.9 | 0.0 | 3.0 | 0.5 | ||||
Summary of the cardiovascular defects identifiable with each imaging technique
| Extracted data | Strengths | Weaknesses | Phenotypes | |
|---|---|---|---|---|
| Histological sections | Tissue morphology and cellular organization |
High resolution Identification of different cell types Marker analyses (e.g. immunostaining) Identification of tissue alterations |
Static images 2D assessment Need to sacrifice the animal Loss of anatomical information due to tissue extraction |
Alterations at the cellular level (e.g. cell specification, cell death, cell proliferation) Alterations at the tissue level (e.g. tissue morphology, inter-tissue organization) |
| Echocardiography |
Haemodynamic parameters (blood velocity and direction) 2D assessment of ventricular size Heart rate |
Only technique to assess haemodynamic parameters Monitoring the progression of phenotypes Fast imaging |
Low tissue resolution 2D assessment |
Altered blood flow due to impaired cardiac pumping capacity Cardiac valve malfunction leading to blood regurgitation Abnormal blood flow in the great vessels Severe alterations of the ventricular size—assessment in 2D Severe arrhythmia |
|
|
Contraction/expansion of cardiac compartments 2D assessment of ventricular size Heart rate |
Sufficient resolution to assess cardiac chambers expansion Monitoring the progression of phenotypes |
Low tissue resolution 2D assessment Heart rate based on indirect measurement Slow imaging acquisition Complex and expensive set up |
Altered contraction/expansion of cardiac compartments Gross morphological alterations of the cardiac compartments—assessment in 2D Severe arrhythmia |
|
|
Volume of the cardiac compartments Spatial organization of the cardiac Gross morphological features of the heart, connecting vessels and cardiac valves |
Preserves heart integrity– no need for organ extraction High resolution at the tissue level Provides spatial information of the heart and surrounding tissues (3D) Data on morphology of connecting vessels |
Static images
Time-consuming analysis Expensive |
Altered volumes of cardiac compartments (static) – assessment in 2D and/or 3D Morphological alterations of the great vessels Gross morphological alterations of the myocardium and cardiac valves Abnormal spatial position/organization of the cardiac compartments and accessory vessels |
| ECG |
Electrophysiology of the heart Heart rate Heart rhythm |
Monitoring the progression of phenotypes Fast imaging | No tissue observation |
Altered cardiac conduction Arrhythmia |